Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers

被引:84
作者
Lin, Shu-Chun
Liu, Chung-Ji
Yeh, Wen-I
Lui, Man-Tin
Chang, Kuo-Wei
Chang, Che-Shoa
机构
[1] Natl Yang Ming Univ, Sch Dent, Taipei 112, Taiwan
[2] Taipei Mackay Mem Hosp, Taipei 100, Taiwan
[3] Taipei Vet Gen Hosp, Dept Dent, Taipei 112, Taiwan
关键词
areca; gene polymorphism; NFKB1; NF-kappa B; mouth; neoplasm;
D O I
10.1016/j.canlet.2005.11.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Areca (betel)-chewing is tightly associated with the high prevalence of oral squamous cell carcinoma (OSCC) in Asians. NFKB1 encodes a 105 kDa protein that can be processed to produce p50 subunit of nuclear factor-kappa B protein complex. A insertion (ins)/deletion (del) polymorphism (-94ins/delATTG) in NFKB1 promoter, which may drive the ins allele two-fold increase in NFKB1 transcription relative to del allele, was recently found. This study identified that the odds ratio in OSCC carrying ins allelotype were 1.78 relative to controls (56.7 vs 41.8%) in subjects more than 50 years old. L allelotype of Heme oxygenase-1 (HO-1), accounting for a long (GT)(n) repeat in HO-1 promoter, is associated with the risks of areca-related OSCC. Subjects carried both NFKB1 ins and HO-1 L allelotypes had significant risks for various subsets of OSCC. OSCC with lymph node metastasis or advanced stage had significantly higher frequency of NFKB1 ins and HO-1 L allelotypes. This study suggested that the functional NFKB1 promoter polymorphism could be valuable for assessment of cancer risk. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 51 条
[1]   Role of reactive oxygen species in the development of cytotoxicity with various forms of chewing tobacco and pan masala [J].
Bagchi, M ;
Balmoori, J ;
Bagchi, D ;
Stohs, SJ ;
Chakrabarti, J ;
Das, DK .
TOXICOLOGY, 2002, 179 (03) :247-255
[2]   Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-κB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines [J].
Bancroft, CC ;
Chen, Z ;
Yeh, J ;
Sunwoo, JB ;
Yeh, NT ;
Jackson, S ;
Jackson, C ;
Van Waes, C .
INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (04) :538-548
[3]   Involvement of Rd/nuclear factor-κB transcription factors in keratinocyte senescence [J].
Bernard, D ;
Gosselin, K ;
Monte, D ;
Vercamer, C ;
Bouali, F ;
Pourtier, A ;
Vandenbunder, B ;
Abbadie, C .
CANCER RESEARCH, 2004, 64 (02) :472-481
[4]   Nuclear factor-kappa B and cancer: its role in prevention and therapy [J].
Bharti, AC ;
Aggarwal, BB .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (5-6) :883-888
[5]   The nuclear factor kappa B (NF-κB):: A potential therapeutic target for estrogen receptor negative breast cancers [J].
Biswas, DK ;
Dai, SC ;
Cruz, A ;
Weiser, B ;
Graner, E ;
Pardee, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10386-10391
[6]   ORAL SUBMUCOUS FIBROSIS - ITS PATHOGENESIS AND MANAGEMENT [J].
CANNIFF, JP ;
HARVEY, W ;
HARRIS, M .
BRITISH DENTAL JOURNAL, 1986, 160 (12) :429-434
[7]   Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers [J].
Chang, KW ;
Lee, TC ;
Yeh, WI ;
Chung, MY ;
Liu, CJ ;
Chi, LY ;
Lin, SC .
BRITISH JOURNAL OF CANCER, 2004, 91 (08) :1551-1555
[8]   Endogenous inhibitors of nuclear factor-κB, an opportunity for cancer control [J].
Chen, F .
CANCER RESEARCH, 2004, 64 (22) :8135-8138
[9]   Genome-wide profiling of oral squamous cell carcinoma [J].
Chen, YJ ;
Lin, SC ;
Kao, T ;
Chang, CS ;
Hong, PS ;
Shieh, TM ;
Chang, KW .
JOURNAL OF PATHOLOGY, 2004, 204 (03) :326-332
[10]  
Chiu CJ, 2002, CANCER EPIDEM BIOMAR, V11, P646